Aug 6, 2026 06:15PM
Aug 6, 2026 06:15PM
Jul 30, 2026 06:42AM
Jul 29, 2026 01:51PM
Jul 29, 2026 06:47AM
Jun 22, 2026 08:30AM
Jun 18, 2026 07:06AM Needham Reiterates Buy Rating on Biogen (BIIB)
Jun 17, 2026 06:59PM
Jun 17, 2026 06:59PM
Jun 4, 2026 05:54AM
Jun 4, 2026 01:00AM
May 14, 2026 08:35AM
May 5, 2026 06:37AM
May 1, 2026 01:05PM Freedom Broker Upgrades Biogen (BIIB) to Buy, raises PT to $245
Apr 30, 2026 07:12AM
Apr 29, 2026 06:55AM
Apr 24, 2026 03:38PM
Apr 20, 2026 07:31AM
Apr 20, 2026 07:30AM
Apr 20, 2026 07:30AM
Apr 2, 2026 06:43AM Biogen (BIIB) PT Raised to $237 at H.C. Wainwright
Mar 31, 2026 03:28PM
Mar 31, 2026 01:28PM
Mar 31, 2026 09:47AM
Mar 31, 2026 09:42AM
Mar 31, 2026 09:36AM
Mar 31, 2026 06:59AM
Mar 31, 2026 06:59AM Biogen to Acquire Apellis, Enhancing the Company’s Growth Portfolio in Immunology and Rare Disease, Bolstering Growth Outlook and Accelerating Expansion into Nephrology
Mar 31, 2026 06:50AM
Mar 18, 2026 09:21AM
Nov 24, 2025 07:30AM
Nov 24, 2025 07:30AM
Nov 14, 2025 04:05PM
Nov 14, 2025 04:05PM
Nov 3, 2025 07:32AM Biogen to present felzartamab data at kidney disease conference
Sep 18, 2025 07:40AM
Sep 18, 2025 07:40AM
Sep 17, 2025 04:30PM
Sep 17, 2025 04:30PM
Jul 2, 2025 10:00AM
Jun 25, 2025 07:31AM
Jun 25, 2025 07:30AM Biogen to Advance Investigational Spinal Muscular Atrophy Asset to Registrational Studies Based on Positive Interim Phase 1 Results
Jun 18, 2025 07:31AM
Jun 18, 2025 07:30AM
Jun 12, 2025 01:00AM
May 27, 2025 07:30AM
Apr 22, 2025 05:14AM
Apr 1, 2025 07:31AM
Apr 1, 2025 07:30AM Organon Acquires TOFIDENCE™ (tocilizumab-bavi), a Commercialized Biosimilar to ACTEMRA® (tocilizumab) Injection, for Intravenous Infusion in the U.S.
Mar 20, 2025 08:00AM

1,177,108 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All